Rating History for AN2 Therapeutics (ANTX) by Evercore ISI

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/9/2024 Liisa Bayko Downgrade Underperform
(In Line)
2.00
(N/A)
2.64
(2.85)
7.95% Details